Direkt zum Inhalt
Merck
Alle Fotos(1)

Wichtige Dokumente

Gesamtdokumentation anzeigen

1359415

USP

Levetiracetam-Racemat

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

(RS)-α-Ethyl-2-oxo-1-pyrrolidinacetamid, 2(RS)-(2-Oxopyrrolidin-1-yl)-butyramid, Etiracetam

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C8H14N2O2
CAS-Nummer:
33996-58-6
Molekulargewicht:
170.21
Beilstein:
1529106
MDL-Nummer:
MFCD00868507
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329750034
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

levetiracetam

Hersteller/Markenname

USP

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

SMILES String

CCC(N1CCCC1=O)C(N)=O

InChI

1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)

InChIKey

HPHUVLMMVZITSG-UHFFFAOYSA-N

Allgemeine Beschreibung

Levetiracetam racemic mixture also know as etiracetam is an stuctural analogue ethylated piracetam drug.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Levetiracetam Racemic Mixture USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Levetiracetam

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

1359404

Levetiracetam, United States Pharmacopeia (USP) Reference Standard

1359437

Levetiracetam-verwandte Verbindung B, United States Pharmacopeia (USP) Reference Standard

1359426

Levetiracetam-verwandte Verbindung A, United States Pharmacopeia (USP) Reference Standard

Y0001253

Levetiracetam, European Pharmacopoeia (EP) Reference Standard

Y0001256

Levetiracetam Unreinheit C, European Pharmacopoeia (EP) Reference Standard

Y0001254

Levetiracetam Unreinheit A, European Pharmacopoeia (EP) Reference Standard

Y0001257

Levetiracetam Unreinheit D, European Pharmacopoeia (EP) Reference Standard

Y0000659

Pyrrolidon, European Pharmacopoeia (EP) Reference Standard

PHR1447

Levetiracetam, Pharmaceutical Secondary Standard; Certified Reference Material

Y0001962

Levetiracetam Unreinheit E, European Pharmacopoeia (EP) Reference Standard

Y0001948

Levetiracetam Unreinheit G, European Pharmacopoeia (EP) Reference Standard

PHR2432

Levetiracetam-verwandte Verbindung B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2428

Levetiracetam Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

Piktogramme

Exclamation markEnvironment
GHS07,GHS09

Signalwort

Warning

Gefahreneinstufungen

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 2

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Aaron M Cook et al.
Neurocritical care, 19(2), 210-214 (2013-08-03)
Increased creatinine clearance and subsequent elevated antimicrobial clearance is evident in many traumatic brain injury (TBI) patients due to augmented renal clearance (ARC). Little is known about the effects of ARC on other renally-eliminated medications, such as the anti-epileptic drug
Can zinc depletion play a role in LEV-induced hair loss? Considerations from a case study.
Rocco Salvatore Calabrò et al.
Epilepsy & behavior : E&B, 29(1), 254-255 (2013-08-14)
Yahya Guvenc et al.
Turkish neurosurgery, 23(5), 617-622 (2013-10-09)
This study aimed to investigate the effects of a new generation antiepileptic agent, levetiracetam, on the neural tube development in a chick embryo model that corresponds to the first month of vertebral development in mammals. Forty-five Atabey® breed fertilized chicken
Wenxia Luo et al.
Bioanalysis, 5(15), 1843-1851 (2013-08-03)
A simple LC-MS/MS method was developed and validated for the quantification of levetiracetam (LEV, Keppra®), a broad-spectrum antiepileptic drug (AED) in rat dried blood spots (DBS). LEV was simply extracted with methanol spiked with adenosine (ADE) as IS before LC-MS/MS
Nurcan Üçeyler et al.
The Cochrane database of systematic reviews, 10(10), CD010782-CD010782 (2013-10-17)
Fibromyalgia (FM) is a clinically well-defined chronic condition of unknown aetiology characterised by chronic widespread pain that often co-exists with sleep problems and fatigue. People often report high disability levels and poor health-related quality of life (HRQoL). Drug therapy focuses
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.